The BioTherapeutics MSc at Leiden University is a research-oriented programme focused on developing modern therapies using biologics and gene-therapy approaches. You learn how to connect immunology and metabolism insights with advanced drug delivery and translational research methods.
The BioTherapeutics Master's program at Leiden University is a research-centric course aimed at innovating modern therapies through biologics and gene-therapy strategies. Students will gain insights into the interplay between immunology and metabolism, alongside advanced drug delivery techniques and translational research methodologies.
The MSc program is structured to progressively develop research skills, from foundational academic knowledge and scientific practices to specialized topics in biotherapeutics and regulatory considerations.
Note: Module titles and course sequencing may vary; check the official program page for the latest curriculum information.
Applicants must possess a bachelor’s degree in Bio-Pharmaceutical Sciences or a closely related discipline from a recognized research university, equivalent to Dutch standards.
Additionally, candidates should have:
Graduates of the BioTherapeutics MSc program are well-equipped to pursue careers in pharmaceutical companies, research institutions, and healthcare organizations. The program’s focus on research and practical application prepares students for roles in drug development, regulatory affairs, and clinical research, contributing to advancements in therapeutic solutions and patient care.
Shortlist scholarships and plan your application — free guidance from our advisors.